OSR HEALTH, INC. Increase (Decrease) in Accounts Payable, Trade
OSR HEALTH, INC. (OSRH) reported Increase (Decrease) in Accounts Payable, Trade of -$958.71 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-08-14
- OSR HEALTH, INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was -$970.16K, a 196.15% decline year-over-year.
- OSR HEALTH, INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $11.45K, a 48.79% decline year-over-year.
- OSR HEALTH, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was $74.52K, a 70.05% decline year-over-year.
- OSR HEALTH, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was -$1.62M.
- OSR HEALTH, INC. increase (decrease) in accounts payable, trade for fiscal 2025 was -$510.23K.
- OSR HEALTH, INC. increase (decrease) in accounts payable, trade for fiscal 2024 was -$344.03K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 3 month as first filed | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$970.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$958.71K 10-Q · filed 2026-08-14 | -$884.19K derived: sum of 3 quarters · filed 2026-08-14 | -$2.50M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $11.45K 10-Q · filed 2026-05-13 | $85.97K derived: sum of 2 quarters · filed 2026-05-13 | -$1.53M derived: sum of 3 quarters · filed 2026-05-13 | -$521.14K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $74.52K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.54M derived: sum of 2 quarters · filed 2026-03-31 | -$532.59K derived: sum of 3 quarters · filed 2026-08-14 | -$510.23K 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$607.11K derived: sum of 2 quarters · filed 2026-08-14 | -$584.75K 10-Q · filed 2025-11-12 | -$335.94K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.03M 10-Q · filed 2026-08-14 | $1.28M derived: sum of 3 quarters · filed 2026-08-14 | $1.23M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $22.36K 10-Q · filed 2026-05-13 | $22.36K 10-Q · filed 2025-05-20 | $271.17K derived: sum of 2 quarters · filed 2026-05-13 | $224.34K derived: sum of 3 quarters · filed 2026-05-13 | -$30.82K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $248.81K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $201.98K derived: sum of 2 quarters · filed 2026-03-31 | -$53.17K derived: sum of 3 quarters · filed 2026-03-31 | -$344.03K 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$46.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$301.99K derived: sum of 2 quarters · filed 2025-11-12 | -$592.84K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$255.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$546.01K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | -$290.86K 10-Q · filed 2025-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |